Literature DB >> 14510255

Epidemiologic investigation of Burkholderia cepacia acquisition in two pediatric intensive care units.

Chawki Loukil1, Carole Saizou, Catherine Doit, Philippe Bidet, Patricia Mariani-Kurkdjian, Yannick Aujard, François Beaufils, Edouard Bingen.   

Abstract

OBJECTIVES: To investigate and describe an outbreak of Burkholderia cepacia in a neonatal intensive care unit (NICU) and a pediatric intensive care unit (PICU), and to report the interventions leading to the cessation of the outbreak.
DESIGN: We conducted an epidemiologic investigation of an outbreak of B. cepacia colonization or infection in two clinical wards during a 35-month period (December 1998 to October 2001).
SETTING: A 500-bed, university hospital-affiliated, tertiary-care pediatric institution in Paris, France, with a 22-bed PICU and 31-bed NICU.
METHODS: Ribotyping was used to determine the genotypes of B. cepacia isolates. Procedures for the maintenance and disinfection of respiratory therapy devices were reviewed.
RESULTS: Thirty-two children were colonized (n = 14) or infected (n = 18) by B. cepacia in 2 wards (28 in the PICU and 4 in the NICU). In the PICU, a single ribotype was found among the isolates obtained from all of the patients except 1, and from the 6 isolates obtained from respiratory therapy devices (ie, heated humidifier water). In the NICU, the isolates obtained from the patients harbored a single ribotype unrelated to that of the epidemic strain isolated in the PICU; no environmental source of infection was found.
CONCLUSION: Two different outbreaks appeared to be associated with 2 ribotypes, 1 of which was linked to patient-to-patient transmission via respiratory therapy devices. Complete elimination of the outbreak was achieved only when disposable, sterilizable, or easy-to-disinfect materials were used in the PICU. The source of infection in the NICU was not found.

Entities:  

Mesh:

Year:  2003        PMID: 14510255     DOI: 10.1086/502272

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  7 in total

Review 1.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

2.  Case Report: Community-Acquired Burkholderia cepacia Pneumonia of a Patient with Pulmonary Tuberculosis.

Authors:  Qiang Li; Li-Ping Ma
Journal:  Am J Trop Med Hyg       Date:  2022-06-13       Impact factor: 3.707

3.  Outbreak of Burkholderia cepacia bacteremia in a pediatric hospital due to contamination of lipid emulsion stoppers.

Authors:  C Doit; C Loukil; A-M Simon; A Ferroni; J-E Fontan; S Bonacorsi; P Bidet; V Jarlier; Y Aujard; F Beaufils; E Bingen
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

4.  Burkholderia cenocepacia bacteremia without respiratory colonization in an adult intensive care unit: epidemiological and molecular investigation of an outbreak.

Authors:  M Katsiari; Z Roussou; K Tryfinopoulou; Ac Vatopoulos; Ed Platsouka; A Maguina
Journal:  Hippokratia       Date:  2012-10       Impact factor: 0.471

5.  Successful cessation of transmitting healthcare -- associated infections due to Burkholderia cepacia complex in a neonatal intensive care unit in a Japanese children's hospital.

Authors:  K Kuzumoto; N Kubota; K Ishii; K Yumoto; Y Ogiso; T Nakamura; T Katsuyama; K Oana; Y Kawakami
Journal:  Eur J Med Res       Date:  2011-12-02       Impact factor: 2.175

6.  Clinical profile, visual outcome and root cause analysis of post-operative cluster endophthalmitis due to Burkholderia cepacia complex.

Authors:  Amit Kumar Deb; Pratima Chavan; Subashini Kaliaperumal; Sujatha Sistla; Haritha Madigubba; Sandip Sarkar; Aswathi Neena
Journal:  Indian J Ophthalmol       Date:  2022-01       Impact factor: 1.848

7.  Respiratory viruses from hospitalized children with severe pneumonia in the Philippines.

Authors:  Akira Suzuki; Socorro Lupisan; Yuki Furuse; Naoko Fuji; Mariko Saito; Raita Tamaki; Hazel Galang; Lydia Sombrero; Melisa Mondoy; Rapunzel Aniceto; Remigio Olveda; Hitoshi Oshitani
Journal:  BMC Infect Dis       Date:  2012-10-23       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.